8052 (8052) Fair Value & Analysis

Consumer Cyclical · Market cap HK$22.5M

8 8052 8052 · HK

PriceHK$0.0410

Fair ValueHK$0.0652

Upside+59.0%

Quality46/100

Watch 8052 for free — get notified when fair value or trend changes. Watch for free

Evidence: Medium Range HK$0.0488 – HK$0.0775

Fair value as of: Jul 2, 2026

From 11 valuation models · updated today

Price vs Fair Value (12 months)

12‑month range HK$0.0340 – HK$0.1150 · fair‑value band HK$0.0488 – HK$0.0775 · the HK$0.0410 price screens below the HK$0.0652 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

8052 (8052) currently trades at HK$0.0410, while our model-based Fair Value estimate is HK$0.0652 — implying the stock looks roughly 59.0% undervalued today. We read business quality at 46/100 (below-average quality), in the Consumer Cyclical sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

Over the trailing twelve months, 8052 generated revenue of HK$111M at a net margin of 0.8%. Revenue declined 28.9% year over year. Net debt stands at HK$20.2M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$111M

Revenue growth (YoY) -28.9%

Net margin 0.8%

Free cash flow HK$16.5M FY2024

Operating margin -0.1%

EPS (TTM) HK$0.0100

More key figures

EPS growth (YoY) -18.1%

Net debt HK$20.2M FY2024

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2020 – FY2024 · reported fiscal years

8052 reported revenue of HK$123M in FY2024 versus HK$158M in FY2020, a compound −6.1%/yr. Reported net income was −HK$9.4M in FY2024.

Revenue −6.1%/yr

FY20 HK$158M

FY21 HK$160M

FY22 HK$58.6M

FY23 HK$95.7M

FY24 HK$123M

Net income

FY20 −HK$31.8M

FY21 −HK$72.0M

FY22 −HK$32.1M

FY23 HK$14.9M

FY24 −HK$9.4M

Is 8052 fairly valued? → Check now

Similar stocks

6 more Resorts & Casinos stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
Las Vegas Sands Corp LVS	$50.25	$40.05	-20%
Galaxy Entertainment Group GXYEF	$3.78	$6.82	+81%
0027 0027	HK$29.42	HK$41.44	+41%
Sands China Ltd SCHYF	$1.80	$2.18	+21%
MGM Resorts International, through its subsidiaries, MGM	$46.91	$20.81	-56%
Wynn Resorts, Limited WYNN	$103.62	$90.24	-13%

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 8052 (8052) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.0652 versus a price of HK$0.0410 — about +59% (undervalued). Model-based estimate, not financial advice.

What is the fair value of 8052?

Our model-based fair value for 8052 is HK$0.0652 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.0410.

What is the quality score of 8052?

8052 has a Quality Score of 46/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 8052 (8052)?

8052 reported trailing-twelve-month revenue of about HK$111M (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 8052?

The net profit margin of 8052 is about 0.8%, meaning it keeps roughly 0.8% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.